<code id='9C1D00A51B'></code><style id='9C1D00A51B'></style>
    • <acronym id='9C1D00A51B'></acronym>
      <center id='9C1D00A51B'><center id='9C1D00A51B'><tfoot id='9C1D00A51B'></tfoot></center><abbr id='9C1D00A51B'><dir id='9C1D00A51B'><tfoot id='9C1D00A51B'></tfoot><noframes id='9C1D00A51B'>

    • <optgroup id='9C1D00A51B'><strike id='9C1D00A51B'><sup id='9C1D00A51B'></sup></strike><code id='9C1D00A51B'></code></optgroup>
        1. <b id='9C1D00A51B'><label id='9C1D00A51B'><select id='9C1D00A51B'><dt id='9C1D00A51B'><span id='9C1D00A51B'></span></dt></select></label></b><u id='9C1D00A51B'></u>
          <i id='9C1D00A51B'><strike id='9C1D00A51B'><tt id='9C1D00A51B'><pre id='9C1D00A51B'></pre></tt></strike></i>

          fashion

          fashion

          author:knowledge    Page View:84
          gilead logo ca remdesivir
          Yichuan Cao/Sipa USA via AP Images

          Gilead Sciences said Monday that Trodelvy, its “smart-bomb” medicine that combines an antibody with chemotherapy, did not significantly extend the lives of patients with metastatic non-small cell lung cancer when given after a first treatment failed.

          The result, from a closely watched study called Evoke-01, will be seen as a disappointment by investors and oncologists alike.

          advertisement

          Drugs like Trodelvy, known as antibody drug conjugates, are one of the hottest areas in oncology. The idea is that these medicines combine an antibody, which is triggered when it binds to a protein on a cancer cell, with a “payload” of chemotherapy that poisons the cancer.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          Akili changes sales model for its ADHD video game treatment
          Akili changes sales model for its ADHD video game treatment

          AdobeAkiliInteractive,whichin2020madewavesbyreceivingFoodandDrugAdministrationclearanceforitsvideoga

          read more
          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more

          Flagship Pioneering startup Sonata Therapeutics lays off 21

          AdobeSonataTherapeutics,astartupcreatedtwoyearsagothroughthemergeroftwoFlagshipPioneeringcompanies,h